Loading company…
Riskpilot
← Back to search
Sign in
Get full access
MerTa Biotech Oy
OY
Dissolved
Y-tunnus 3214895-8
Pääskysillankatu 9-B78
Research and experimental development on natural sciences and engineering · NACE 7210
Est. 2021
0 employees
Watchlist
Share
Overview
Financials
People & ownership
Related companies
Revenue 2024
EUR 0
EBITDA margin
—
-28% vs 2022
Equity ratio
17.9%
Financial strength
Net profit 2024
EUR -3K
+37% vs 2022
EBITDA — year on year
EUR millions
0M
-0M
-1M
-1M
-1M
0M
2022
0M
0%
2024
Key figures
Annual report 2024
Revenue
EUR 0
—
EBITDA
EUR -7K
-28%
Net profit
EUR -3K
+37%
Total assets
EUR 11K
-35%
Equity
EUR 2K
-71%
Employees
0
—
Company information
Legal name
MerTa Biotech Oy
Y-tunnus number
3214895-8
Legal form
Osakeyhtiö
NACE code
7210 · Research and experimental development on natural sciences and engineering
Founded
31. toukokuuta 2021
Share capital
EUR 0
Employees
0
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Company purpose
Tieteellinen tutkimus ja kehittaminen
Contact
Address
Pääskysillankatu 9-B78
Phone
+3580442453947
Email
trway04@gmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
Visit risika.com
Explore
Companies in Research and experimental development on natural sciences and engineering
Companies in Turku
All Finland companies
Revenue
EUR millions
0M
0M
1M
1M
1M
0M
2022
0M
2024
EBITDA
EUR millions
0M
0M
1M
1M
1M
0M
2022
0M
2024
Income statement
EUR thousands
Item
2022
2024
Revenue
57
0
Staff expenses
−25
−0
EBITDA
−5
−7
Depreciation & amort.
—
−0
EBIT
−5
−7
Net financials
−0
0
Profit before tax
−5
−7
Tax
−0
−3
Net profit
−5
−3
Balance sheet
EUR thousands
Item
2022
2024
Total assets
18
11
Equity
7
2
Long-term debt
—
0
Short-term debt
10
15
Total debt
10
15
Financial ratios
5-year trend
EBITDA margin
-663100.0%
This company
15.8%
Market median
-4196935% vs market
2022
2024
Equity ratio
17.9%
This company
38.2%
Market median
-53% vs market
2022
2024
Return on equity
-165.9%
This company
18.4%
Market median
-1002% vs market
2022
2024
Net profit margin
-340100.0%
This company
8.1%
Market median
-4198865% vs market
2022
2024
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
2022
2024
Debt / equity
4.58×
This company
0.62×
Market median
-639% vs market
2022
2024
Annual reports & filings
Annual report 2024
Filed via PRH / YTJ · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2022
Filed via PRH / YTJ · Period 2022-01-01 – 2022-12-31
View
PDF
Management
Actively employed in the business
Name
Role
Member since
Current (1)
ME
Merja Elina Rantapirkola
Deputy Member
Deputy Member
2021
Board of directors
Non-executive oversight
Name
Role
Member since
Current (1)
TR
Tapio Rantapirkola
Board of Directors
2021
Shareholders
As of last annual report
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
Company hierarchy
No registered parent or subsidiaries
Board network connections
Board members of MerTa Biotech Oy also hold positions in
0
other companies.
Person
Role here
Other companies
Merja Elina Rantapirkola
Deputy Member
0 companies
Tapio Rantapirkola
Board of Directors
0 companies